[183 Pages Report] The Custom Antibody Market size was estimated at USD 407.63 million in 2023 and expected to reach USD 478.23 million in 2024, at a CAGR 20.42% to reach USD 1,497.58 million by 2030.
Custom antibodies are specifically designed and produced to target a particular antigen and are custom-made and tailored to a specific requirement, such as binding to a particular protein region or recognizing a special post-translational modification. The custom antibody market has experienced growth in recent years due to factors such as an increase in R&D activities and a rise in funding from the government to carry out the research. In addition, the increase in therapeutics of antibodies, expansion of drug pipeline, and rise in collaborations of industry and academic institutions for research are significantly driving the market’s growth. Surging demand for protein therapeutics and the production of custom antibodies are adding to the driving force for market growth. However, high expenses in process and the time required for production are restricting the market growth for the last few years. Nevertheless, developments in research infrastructure enable emerging countries to continue to support custom antibody startups and SMEs, strengthen the emerging bioeconomy, and help unlock the societal benefits of custom antibody.
Regional Insights
Increasing demand for customized diagnostics and treatments has encouraged players from the U.S., the UK, Germany, China, and India to invest in product development and expansion strategies, accelerating the market growth across North America, Europe, and Asia-Pacific regions. North America has been witnessed to hold a significant market share, owing to the presence of leading companies, extensive government funding, and increased research activities in the region. Additionally, large-scale cancer & genomics research programs have been conducted by universities in the U.S. and Canada that have accelerated the progress in the biotechnology sector, thereby increasing the demand for high-throughput technology solutions in laboratory workflows. North America is expected to grow over the forecast period owing to the rapid adoption of advanced technological solutions, high investments in R&D, and rising wages of skilled personnel. The markets in Europe and the Asia-Pacific are estimated to grow rapidly, which can be attributed to the increasing interest of key global players in capturing regional revenue share by expanding into emerging markets. Global investors are increasingly investing in China, Germany, and India due to economic developments. Regional players are also strengthening their presence in the global custom antibodies market.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Custom Antibody Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Custom Antibody Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Custom Antibody Market, highlighting leading vendors and their innovative profiles. These include Abbiotec, Inc., Abcam PLC, ABclonal, Inc., Abgenex Pvt. Ltd., Abimate Pharmaceutical (Shanghai) Co., Ltd., Abnova Corporation, Acrobiosystems Inc., Agilent Technologies, Inc., Alta Bioscience Limited, Bio Basic Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BioChain Incorporated, Bioklone Biotech Private Limited, BioLegend, Inc. by PerkinElmer, Inc., Biosynth Ltd., Boster Biological Technology, BTL Biotechno Labs Private Limited, Capralogics, Inc., Cell Signaling Technology, Inc., CiteAb Limited, Creative Biolabs, Creative Diagnostics, CSBio (Shanghai) Ltd., Cusabio Technology LLC, Davids Biotechnologie GmbH, Elabscience, evitria AG, GenScript Biotech Corporation, Imgenex India Pvt. Ltd., Innovagen AB, Inotiv, Inc., Kaneka Eurogentec S.A., Laboratory Corporation of America Holdings, Merck KGaA, Metabion International AG, MyBiosource, Inc., OriGene Technologies, Inc., Oy Medix Biochemica AB, Pacific Immunology, PhosphoSolutions, ProMab Biotechnologies, Inc., ProSci Incorporated, ProteoGenix SA, RayBiotech Life, Inc., Rockland Immunochemicals, Inc., Sino Biological, Inc., The Antibody Company, Thermo Fisher Scientific, Inc., and YenZym Antibodies, LLC.
Market Segmentation & Coverage
This research report categorizes the Custom Antibody Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Service
- Antibody Development
- Antibody Fragmentation & Labeling
- Antibody Production & Purification
- Source
- Mice
- Rabbit
- Research Area
- Cardiovascular Diseases
- Immunology
- Infectious Diseases
- Neurobiology
- Oncology
- Stem cells
- End Users
- Academic & Research Institutes
- Contract Research Organizations
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Application
- Research
- Therapeutics
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Custom Antibody Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Custom Antibody Market?
- What are the technology trends and regulatory frameworks in the Custom Antibody Market?
- What is the market share of the leading vendors in the Custom Antibody Market?
- Which modes and strategic moves are suitable for entering the Custom Antibody Market?
US $
Euro €
GBP £